NARROW MARGIN

Clinical trials for NARROW MARGIN explained in plain language.

Never miss a new study

Get alerted when new NARROW MARGIN trials appear

Sign up with your email to follow new studies for NARROW MARGIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immunotherapy plus radiation aims to stop liver cancer recurrence

Disease control Recruiting now

This phase 3 trial tests whether combining radiotherapy with the immunotherapy drug sintilimab can better prevent liver cancer from coming back after surgery, compared to the standard TACE procedure. The study enrolls 286 adults with high-risk features like narrow surgical margin…

Matched conditions: NARROW MARGIN

Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

NARROW MARGIN

Get alerted when new NARROW MARGIN trials appear

Immunotherapy plus radiation aims to stop liver cancer recurrence